biologic

Humulin N

insulin isophane human

Loss of exclusivityOctober 1994projected — 12-year biologic exclusivity estimate
CompanyEli Lilly and Company

Drug detail

Brand nameHumulin N
Active ingredientinsulin isophane human
Strength300UNITS/3ML (100UNITS/ML)
Dosage formInjectable Suspension
RouteSubcutaneous
ModalityBiologic
FDA approvalOctober 1982
Marketing statusOTC

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Humulin N patent cliff — loss of exclusivity October 1994 | CliffBio